Shanghai MicroPort MedBot (Group) (HKG:2252) completed the placement of 12.9 million shares at HK$9.10 apiece to at least six investors, allowing it to raise HK$114.08 million in net proceeds.
Proceeds will go toward the medical device maker's overseas product registration and commercialization, product optimization and upgrades, general corporate purposes, and working capital, according to a Friday disclosure with the Hong Kong Exchange.
Price (HKD): $8.45, Change: $-0.05, Percent Change: -0.59%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments